Jobs / United States / Regeneron Pharmaceuticals INC
Executive Director, Head of Strategy & Transformation
Regeneron Pharmaceuticals INC · 🇺🇸 SLEEPY HOLLOW
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 40 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Regeneron Pharmaceuticals INC paid sponsored hires in similar roles1 certified filing for “Executive Director Financial Planning & Analysis” (Financial Managers) in NJ: $317k–$317k, median $317k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Regeneron Pharmaceuticals INC
The US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 40 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Regeneron Pharmaceuticals INC →
About the role
Executive Director, Head of Strategy & Transformation Regeneron’s Global Technology, Engineering, Operations & Application Managed Services (GTEO) runs the technology behind our research, manufacturing, and commercial operations and the $15B+ revenue pipeline they drive. As the company has grown across Europe, Asia-Pacific, and beyond, our technology investments and modernization work have grown with it and so has the need to lead all of it as one coherent program rather than a set of separate efforts. Security and AI now run through everything we build, and the strategy must treat them as built-in from the start, not bolted on later. We are creating this role to do exactly that: put one senior leader in charge of where GTEO is headed, what we invest in, and how we transform the estate to support the next phase of the company’s growth. The Executive Director, Head of GTEO Strategy & Transformation owns strategy, planning, design, and transformation for the GTEO organization. You will assist in setting the multi-year direction and the standards that guide it, own the investment portfolio and the budget for the function, and lead the major transformation programs through to results. You set the direction and govern the portfolio; the delivery teams continue to execute the projects. You will report to the Global Head of GTEO and be a lead voice on technology strategy and transformation for the organization with senior leaders inside and outside Regeneron. Where and When: This is an on-site position 4 days/week, primarily based at our Sleepy Hollow, NY or Warren, NJ office. If eligible, we can offer relocation benefits; we cannot offer a fully remote option. A typical day in this role looks like: • Assisting with the multi-year strategy and architectural direction for GTEO, translating enterprise priorities into a funded roadmap and setting the standards that govern how we invest and modernize. • Owning the investment portfolio and the budget end to end: prioritizing and funding against business value and capacity. • Leading the major transformation programs from strategy through delivered value, accountable for the business case and the benefits we committed to. • Owning and shaping how capacity is allocated so the roadmap is one we can fund, staff, and sequence; procurement and the delivery teams own contracts and execution. • Setting direction on technology lifecycle, refresh, and technical-debt retirement as part of the roadmap, with delivery teams owning execution. • Prioritizing and funding transformation initiatives sourced from Business Process Excellence & User Experience (BPE/UX) process and experience redesigns and Enterprise Architecture's technology roadmap — completing the sequential model in which BPE/UX designs the experience, EA architects the technology, and S&T funds and delivers. • Building security and resilience into the strategy and architecture from the start, setting the standards in close partnership with the CISO organization, which owns security operations and policy. • Setting the strategy for how AI is adopted across GTEO, from the platforms and guardrails to the operating model, so the organization scales AI safely and gets real value from it. • Building and structuring the transformation functions across strategy, architecture, portfolio, and operations. • Partnering with senior leaders across Research, Commercial, IOPS, and our India GCC, and advising technology leadership, to keep the organization’s strategy tied to the business and execution aligned to the roadmap. • Representing the program to executive stakeholders with clear reporting, metrics, and audit-ready governance, and benchmarking against industry peers to keep us sharp. This role might be for you if: • You have led strateg